XOSPATA

astellas pharma canada inc🇨🇦 Health Canada

Approval Id: c67ae51647b8f8b6
Drug Approval Canada Name: XOSPATA
Product Name: XOSPATA
Status: Marketed
Status Date: 2020-02-03
Original Market Date: 2020-02-03
Din: 02495058
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EX13 GILTERITINIB
Atc Name: l 01 ex 13
Aig Number: 0162011001
Company Name: astellas pharma canada inc
Company Address: 675 Cochrane Drive, West Tower, Suite 650, Markham, Ontario, Canada, L3R 0B8

GILTERITINIB (GILTERITINIB FUMARATE)

40 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

c67ae51647b8f8b6

Type

Standard